Gene Query: APOL1

Dataset Description Geneva Score
Transcriptional responses of human insulinoma cells to acute cytokine exposure 179.27
The impact of pro-inflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes 153.48
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 151.04
RNA-seq of cancer-associated fibroblasts (CAF) treated with PBS or extracellular vesicles (EV) from MCF10A or MDA-MB-231 cells 133.12
GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling 125.32
VAMP8 contributes to TRIM6-mediated type-I interferon antiviral response upon West Nile virus (WNV) infection 112.36
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 87.89
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 87.89
Statins modulate endothelial transcriptional profile by inhibiting EZH2 86.43
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 86.31
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 86.31
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 77.56
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 69.03
Transcriptome analysis of human airway epithelium infected by Human Bocavirus 1 68.07
Transcriptomic profiling of human coronary artery endothelial cells under laminar shear stress (LS), oscillatory shear stress (OS) and static culture (ST) 67.0
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 66.15
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 65.23
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 63.65
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes 62.26
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes [RNA-Seq] 62.26
Transcriptional change of THP-1 after HSV-1UL37WT or HSV-1UL37C819S 61.63
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells [RNA-seq] 57.71
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells 57.71
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 56.98
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 56.2
Effect of Influenza virus infection on lncRNA expression in A549 cells 55.08
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 54.52
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 51.6
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 50.9
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 49.99
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 49.99
Interferon-γ Converts Human Microvascular Pericytes into Negative Regulators of Alloimmunity through Induction of Indoleamine 2,3-Dioxygenase 1 49.96
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 49.49
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 49.01
ARID1A regulates condensin II distribution and chromosomal partition 48.59
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 48.59
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 45.58
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 45.58
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 45.03
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 45.03
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 44.79
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 44.7
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 43.39
Macrophage Ad5f35 M2 Challenge 43.35
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy 42.59
Cellular response to hepatitis E virus (HEV) infection 40.98
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 40.57
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 39.81
Gene expression profiling of KSHV-infected periodontal ligament cells 39.68
Effects of rFVIIIFc on human macrophages 39.47
H1609088 Human RNA-Sequencing 39.03
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 37.94
MiR-26 dampens IL-6 production by down-regulating TNF-a/NF-kB signaling through silencing HMGA1 and MALT1 and not by directly targeting IL-6 mRNA 37.25
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 36.21
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 35.98
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 35.98
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 35.63
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 35.3
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 33.77
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 33.24
Lentiviral CRISPR Epigenome Editing of Inflammatory Receptors as a Gene Therapy Strategy for Disc Degeneration 31.79
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 31.75
Comprehensive RNA sequencing of healthy human endometrium at two time points of the menstrual cycle 30.65
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 30.5
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 30.5
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 30.4
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 30.01
Genome-wide analysis of Dengue virus 2 infected cells 29.62
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 29.14
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes [RNA-seq] 28.54
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes 28.54
Genome wide expression change by RNF168 knocking down in NEC cells 28.35
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 28.02
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 27.46
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 27.46
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 27.24
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 27.12
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 27.03
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 26.53
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 26.3
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 26.27
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 25.75
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 25.49
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 25.39
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 25.35
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 25.35
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 25.21
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 25.2
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 25.2
RNASeq of mouse, human, and non-human primate primary dermal fibroblasts to poly(I:C) transfection 25.0
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 24.74
Characterization of the Merkel cell carcinoma miRNome 24.72
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 24.67
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 24.04
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 23.95
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 23.58
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 23.53
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 23.46
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 23.31
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 23.09
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 22.92
Total RNA sequencing of WT intestinal orgaonids. 22.88
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 22.82
Pomalidomide inhibits PD-L1 induction to promote anti-tumor immunity 22.67
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 22.41
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 22.19
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 22.09
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 21.84
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 21.8
Macrophage Ad5f35 PhenoMap 21.46
IRF1 regulates IFN dependent and independent gene expression 21.45
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 20.9
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 20.9
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 20.85
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 20.58
Transcriptomic profiles of nonpregnant and term pregnant human myometrial tissues 20.34
Nonpregnant and term pregnant human myometrial tissues 20.34
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 19.71
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 19.63
RNA-seq in HepG2 and IMR90 cells 19.58
Evolution of a transcriptional regulator from a transmembrane nucleoporin 19.58
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 19.47
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 19.18
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 19.17
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 19.15
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 19.15
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 18.99
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 18.93
IRF2 is a master regulator of human keratinocyte stem cell fate 18.9
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 18.9
Expression data from miR340 overexpressing human A549 cells 18.88
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 18.86
Effect of hypoxia and TGFβ1 on gene expression in HPF fibroblast cells 18.84
The effect of PPARG inhibition on human angiomyolipoma cells 18.71
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 18.54
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 18.44
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 18.31
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 18.25
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 18.18
A549 cells and MSR-A549 cells 18.18
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 18.13
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 17.91
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 17.7
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 17.61
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells 17.55
mRNA sequencing analysis of cultured human primary airway epithelial cells upon exposure to PMN exosomes 17.48
Transcriptomic profile of human embryonic renal corpuscles 17.47
RNA-Seq analysis of NKX2.2 knockdown in human pancreatic islets 17.45
NKX2.2 17.45
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 17.42
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells 17.39
DECIDUALIZATION INDUCES A SECRETOME SWITCH IN THE PERIVASCULAR NICHE CELLS OF THE HUMAN ENDOMETRIUM 17.33
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 17.31
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 17.21
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization 17.08
Transcriptome wide analysis of classically and alternatively activated macrophages 16.99
Generation and functional characterization of MDSC-like cells 16.6
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 16.58
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 16.56
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 16.48
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 16.39
Transcriptome Analysis and Functional Identification of Adipose-Derived Mesenchymal Stem Cells in Secondary Lymphedema 16.29
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 16.18
MicroRNA-125a-5p overexpression in human macrophages 16.14
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 16.1
NAPRT activation of macrophages 16.07
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 16.03
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 15.94
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 15.71
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 15.7
UBC9 knockdown in bladder cancer T24 cell lines 15.66
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 15.65
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 15.58
circNFIB suppresses lymphatic metastasis of pancreatic cancer 15.54
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 15.52
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 15.51
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 15.5
RNA-seq of MCF10A cells and CAF 15.41
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 15.13
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 14.98
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 14.98
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 14.93
Primate transcript and protein expression levels evolve under compensatory selection pressures 14.79
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 14.57
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 14.52
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 14.52
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 14.28
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 14.28
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 14.15
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 14.15
Gene expression patterns define the hepatocyte-like cells derived by different strategies 14.15
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 14.12
Regionally distinct astrocyte interferon signaling promotes blood-brain barrier integrity and limits immunopathology during neurotropic viral infection 14.1
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 14.07
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 13.99
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 13.93
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 13.76
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 13.71
The evolution of N6-methyladenosine in primates 13.53
Ro60-knockout cells 13.27
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 13.16
Effect of ILF3 on translation during homeostasis and the antiviral response 13.15
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 13.14
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 12.97
Landscape of H3K4me3 in human CD19 cells 12.93
Electronic cigarettes 12.92
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 12.84
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 12.8
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 12.72
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 12.72
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 12.69
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 12.62
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 12.58
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 12.57
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 12.55
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 12.53
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 12.53
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 12.34
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 12.16
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 12.16
Controlling for gene expression changes in transcription factor protein networks. 12.15
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 11.97
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 11.88
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 11.87
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 11.82
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 11.81
A549 cell transcriptome responses to infection with H7N9 influenza virus 11.73
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 11.67
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 11.67
Transcriptome analysis of virus infected tissues 11.59
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 11.54
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 11.5
Role of CD133 molecule in WNT response and renal repair 11.46
Transcriptome profiling of Normal and Cancerous Prostate Cells 11.44
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 11.43
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 11.38
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 11.14
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 11.12
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 11.07
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 11.06
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 11.03
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 11.02
RNAseq analysis of ESRP regulated splicing events in prostate cancer 10.97
The role of the Calcium-Sensing receptor in colorectal cancer 10.94
Non-coding regions are the main source of tumor-specific antigens 10.93
Non-coding regions are the main source of tumor-specific antigens [human] 10.93
Identification and Initial Functional Characterization of SENCR, a Long Non-Coding RNA Enriched in Human Vascular Cells 10.87
ELP1 splicing correction reverses proprioceptive sensory loss in familial dysautonomia 10.87
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 10.84
Iron response of HepG2 cells 10.77
Integrin signaling regulates YAP/TAZ to control skin homeostasis 10.73
CD74 role in transcription regulation [RNA-seq] 10.68
CD74 role in transcription regulation 10.68
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 10.67
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 10.66
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 10.66
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 10.62
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 10.49
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 10.42
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 10.4
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 10.39
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 10.34
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 10.32
Transcriptome of Stabilin-1 siRNA transfected human monocytes 10.3
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 10.28
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 10.28
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 10.17
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis 10.14
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis: Expression data (RNA-seq) 10.14
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 10.14
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 10.1
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 9.98
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 9.94
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 9.94
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 9.94
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 9.91
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 9.86
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 9.83
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 9.81
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 9.79
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 9.74
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 9.74
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 9.73
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 9.58
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 9.57
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 9.5
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 9.41
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 9.35
mRNA differential expression analysis in a human ex vivo model of chronic wounds 9.3
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 9.26
CD86 regulates a pro-survival signal in myeloma cells 9.2
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 9.17
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 8.94
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 8.94
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 8.93
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 8.85
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 8.82
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 8.79
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 8.79
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 8.71
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 8.61
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 8.61
Effect of Hotair overexpression in human breast cancer cell lines 8.6
RNA-seq of IL-4 stimulated human keratinocytes 8.52
iPSC-Derived Cholangiocytes 8.51
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 8.46
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 8.46
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 8.34
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 8.32
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 8.31
Changes in human endometrial gland transcriptome over the window of implantation 8.29
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 8.16
The phosphatidylinositol 3-kinase pathway as a potential therapeutic target in bladder cancer 8.15
RNA-Seq in neutrophils from Antiphospholipid Syndrome 8.06
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 8.02
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 7.99
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 7.98
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 7.92
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 7.92
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 7.92
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 7.92
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 7.75
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 7.75
High-Throughput Kinetic Analysis of Fractional Killing 7.75
Generation of KRAS signatures using immortalized isogenic lung cells. 7.68
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 7.53
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 7.52
Effect of hyperfractionated irradiation (HFRT) of prostate primary basal cells (PrEPs) on the transcriptome 7.26
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 7.19
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 7.16
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 7.16
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 7.09
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 7.0
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 6.93
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 6.93
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 6.92
Zone dependent distinctive gene expression profile of the normal human liver tissue 6.9
Clinker: visualizing fusion genes detected in RNA-seq data 6.79
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 6.79
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 6.76
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 6.73
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 6.69
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 6.69
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 6.66
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 6.57
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 6.57
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 6.54
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 6.48
Evolutionary origin and functional divergence of stem cell homeobox genes in eutherian mammals 6.45
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 6.32
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 6.26
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 6.25
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 6.23
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 5.91
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 5.87
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 5.87
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 5.79
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 5.77
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 5.73
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig 5.61
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 5.61
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 5.61
Gene expression profile of multiple myeloma cell lines treated with CB-5083 5.6
RNA seq_PDX2_SHP099 5.49
RNA-Seq analysis of human colorectal cancer with liver metastasis 5.4
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 5.38
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 5.22
Random mono-allelic expression in MECP2-mutated cells 5.2
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 5.14
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 4.99
Gene expression profile difference among renal location in a stone former 4.94
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 4.9
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 4.77
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 4.72
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 4.72
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 4.72
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 4.71
Transcriptome Profiling of Human Primary Monocytes 4.68
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 4.63
Genome-wide identification of cancer-specific alternative splicing in circRNA 4.56
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 4.45
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 4.45
Next Generation Sequencing of human SMA and healthy control Motor Neurons 4.45
Fbxo32 mediated gene expression program underlies EMT and metastasis 4.4
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 4.37
Transcriptomes of human monocytes after ex vivo exposure to uric acid 4.35
RNA-seq data of adipocytes co-cocultured with OVCAR5 in Boyden chamber (4d) 4.35
Tpl-2 small molecule project 4.23
Tpl-2 and MEK small molecule inhibitors 4.23
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 4.16
Regulating Interleukin-2 activity with engineered receptor signaling clamps 4.12
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 4.09
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 4.07
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 3.96
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 3.96
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 3.85
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 3.7
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 3.7
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 3.59
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 3.53
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 3.5
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 3.47
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 3.45
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 3.43
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 3.42
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 3.39
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 3.38
DAOY-Notch1/Notch2 knockout: transcriptome comparison 3.3
Persistence of stem cell metabolism in cancers as a failure of differentiation 3.29
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 3.27
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 3.27
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 3.27
Finding missing proteins from epigenetically manipulated human cells 3.21
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 3.14
U2AF1 mutations alter splice site recognition in hematological malignancies 3.12
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 3.11
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 3.06
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription [RNA-Seq] 3.03
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription 3.03
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 2.89
Transcriptome profiling of de-differentiated chondrocytes over-expressing miR-138 or miR-181ab1 during osteogenic induction 2.86
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 2.8
Hepatic transcriptome of pediatric hepatoblastoma. 2.76
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 2.74
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 2.67
Loss of endometrial plasticity in recurrent pregnancy loss 2.67
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 2.65
MHC Transcriptomic landscape at haplotype-specific resolution 2.64
Gene expression alterations of pancreatic intraepithlial neoplasia 2.55
Gene expression profiles of brain endothelial cells during embryonic development at bulk and single-cell levels 2.54
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 2.52
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 2.52
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 2.52
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 2.51
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 2.47
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 2.47
RNA-seq of cancer cell lines treated with T-025 2.32
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 2.22
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 2.21
Transcriptional Profiling of Werner Syndrome (WS) iPSC-derived MSC and the isogenic gene-edited controls 1.95
Defective structural RNA processing in relapsing-remitting multiple sclerosis 1.93
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 1.87
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 1.87
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 1.71
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 1.61
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 1.56
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 1.54
Aging signatures developed from a longitudinal study design are dominated by reduced transcription of genes involved in protein synthesis. 1.31
RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age 1.31
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 1.3
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 1.26
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 1.23
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 1.19
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 1.19
Gene expression of collecting duct carcinoma of the kidney 1.19
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 1.18
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 1.18
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 1.11
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 1.1
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 1.02
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 0.91
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.88
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 0.88
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 0.84
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 0.81
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 0.81
Molecular analysis of renal cell carcinoma with unclassfied histology 0.8
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 0.8
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 0.78
RNA sequencing of human pancreatic cancer cell lines 0.67
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 0.64
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 0.56
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 0.55
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.52
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 0.52
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 0.51
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 0.48
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 0.47
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 0.46
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 0.42
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 0.42
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 0.28
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 0.26
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.21
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 0.2
RNA expression profiles comparing primary and omental ovarian carcinoma samples 0.19
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells II 0.18
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 0.14
Transcriptomic analysis of human macrophages in 3D 0.13
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 0.13
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 0.11
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 0.11
Global gene expression differences between blood- and lymphatic-specific human dermal microvascular endothelial cells 0.1
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 0.09
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.06
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM 0.04
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.02
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 0.02
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants 0.01
Transcriptome of human ILC2s; primary vs IL-1b-primed 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation